“Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital”. 2022. University Heart Journal 18 (1): 10-13. https://doi.org/10.3329/uhj.v18i1.57874.